Sera Prognostics (SERA) FCF Margin Growth (3y) (2023 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 38.00
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 30.00
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 943.00
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 96.00
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -2,196.00
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -20.00
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 2,679.00
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -461.00
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 417.00
10 Sera Prognostics 30.02 Mn 30.02 Mn -28,000.00 -5.78 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -5.78 Mn
Dec 31, 2025 -5.31 Mn
Sep 30, 2025 -3.07 Mn
Jun 30, 2025 -2.20 Mn
Mar 31, 2025 528,421.00
Dec 31, 2024 1.20 Mn
Sep 30, 2024 1.81 Mn
Jun 30, 2024 688,583.00
Dec 31, 2023 5.39 Mn
Sep 30, 2023 6.20 Mn